Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20080850996external-prioritypatent/EP2220047B1/en
Application filed by Clanotech AbfiledCriticalClanotech Ab
Publication of CY1116412T1publicationCriticalpatent/CY1116412T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Μια ένωση του τύπου (I) καθώς και φαρμακευτικώς αποδεκτά άλατα αυτής. Μια φαρμακευτική σύνθεση περιέχουσα μια θεραπευτικώς αποτελεσματική ποσότητα της ένωσης. Η ένωση είναι χρήσιμη για τη θεραπευτική αγωγή καρκίνου, διαβητικής αμφιβληστροειδοπάθειας, εκφύλισης της ωχράς κηλίδας λόγω ηλικίας, φλεγμονής, αποπληξίας, ισχαιμικού μυοκαρδίου, σκληραθηρωμάτωσης, οιδήματος της ωχράς κηλίδας ή ψωρίασης.A compound of formula (I) as well as pharmaceutically acceptable salts thereof. A pharmaceutical composition containing a therapeutically effective amount of the compound. The compound is useful for the treatment of cancer, diabetic retinopathy, macular degeneration due to age, inflammation, stroke, ischemic myocardium, scleritis, macular edema, or swelling.
CY20151100522T2007-11-152015-06-17
KINOLIN PRODUCTS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE
CY1116412T1
(en)
DERIVATIVES OF QUINOLINA 057; A PROCESS FOR PREPARATION; A PHARMACEUTICAL COMPOSITION; THE PREPARATION OF THIS AND THE USE OF THE COMPOUND TO PREPARE A MEDICINAL PRODUCT